Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 09/30/10
End: 11/30/11
Due: 11/30/12
Phase: N/A
Priority: Normal
Start: 11/15/17
End: 04/20/18
Due: 04/20/19
Phase: N/A
Priority: Normal
Start: 12/15/15
End: 09/09/16
Due: 09/09/17
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Direct Renin Inhibition and the Kidney | NCT01217736 | Vitae Pharmaceuticals, Inc. | user2@example.com | None | 2010-09-30 | 2011-11-30 | 2012-11-30 | - | - | 2025-07-14 |
| AGN-242428 in the Treatment of Plaque Psoriasis | NCT03339999 | Vitae Pharmaceuticals, Inc. | user2@example.com | None | 2017-11-15 | 2018-04-20 | 2019-04-20 | - | - | 2025-07-14 |
| An Ascending Multiple Dose Study of VTP-38543 in Adult Participants With Mild to Moderate Atopic Dermatitis | NCT02655679 | Vitae Pharmaceuticals, Inc. | user2@example.com | None | 2015-12-15 | 2016-09-09 | 2017-09-09 | - | - | 2025-07-14 |